ENHYPEN Concludes Spectacular Sold-Out U.S. Leg of WALK THE LINE World Tour

Rosa Gulliver
Aug 18
3 min read

Rosa Gulliver of TINYGMUSIC | August 18, 2025

ENHYPEN WRAP SOLD-OUT U.S. LEG OF ‘WALK THE LINE’ WORLD TOUR WITH GRAND FINALE AT BMO STADIUM

ENHYPEN have officially wrapped the U.S. leg of their third world tour, ENHYPEN WORLD TOUR ‘WALK THE LINE’ (hereinafter ‘WALK THE LINE’), with a grand finale at Los Angeles’ BMO Stadium on August 16. The concert marked the end of a completely sold-out U.S. run, further solidifying the septet’s status as global performance powerhouses.

Following a dynamic two-night kick-off at UBS Arena in Belmont Park, NY (August 6 & 7), ENHYPEN brought ‘WALK THE LINE’ to Chicago (August 9), Houston (August 12 & 13) and Los Angeles. The tour spotlighted the group’s elevated stagecraft, emotional storytelling and deepening connection with their fanbase, ENGENEs. This connection was especially evident after their ground-breaking Coachella debut this past April where Forbes praised them for defining “a new level of global stage presence,” while Billboard commended them for “keeping the crowd engaged at every turn.”

Launched with two stadium shows in Korea last October, ‘WALK THE LINE’ has since journeyed through Japan, the Philippines, Thailand and now the U.S., totalling over 20 shows across 12 cities worldwide.

Set against a backdrop of self-discovery and shared destiny, ‘WALK THE LINE’ brought ENHYPEN’s evolving narrative to life through cinematic VCRs, dramatic staging and an electrifying setlist spanning their discography.

The show kicked off with a high-octane run of “Brought The Heat Back,” “FEVER,” “ParadoXXX Invasion” and “Future Perfect (Pass the MIC),” as the members took the stage in sleek custom Prada ensembles.

Fans were then treated to the group’s debut single “Given-Taken,” followed by unit stages. JAY, JAKE and SUNGHOON delivered a fierce rendition of “Lucifer” while JUNGWON, HEESEUNG, SUNOO and NI-KI showcased a powerful performance of “Teeth.” The full group returned for the hard-hitting “Blessed-Cursed,” mesmerising “Fatal Trouble” and fan-favourite “Bite Me.”

“Your Eyes Only” was up next, followed by “Loose.” After performing the full version, HEESEUNG launched into an a cappella reprise, a moment Billboard hailed as one of the tour’s highlights. His voice carried through the stadium as fans joined in a singalong.

From there, the energy surged once more with “Scream,” “Tamed-Dashed,” “Sweet Venom” and “Go Big or Go Home” before the members delivered a mix of cinematic vocals and captivating visuals for “Moonstruck,” “XO (Only If You Say Yes) (English Ver.),” “No Doubt,” and “Bad Desire (With or Without You) (English Ver.).”

An explosive double encore capped off the night with “Helium,” “Paranormal Love,” an EDM version of “Drunk-Dazed” and a victorious reprise of “Go Big or Go Home,” sending the crowd into one last euphoric frenzy.

Before leaving the stage, the members teased that they’re working on a new album, sparking excitement among fans eager for what’s to come.

With the U.S. leg now complete, ENHYPEN are preparing to kick off their first-ever Europe tour, beginning August 22 in London with additional stops in Manchester (August 25), Amsterdam (August 28), Brussels (August 30), Berlin (September 1) and Paris (September 3).

More information on upcoming international tour dates is available at walkthelinetour25.com.

About ENHYPEN

ENHYPEN, consisting of members JUNGWON, HEESEUNG, JAY, JAKE, SUNGHOON, SUNOO, and NI-KI have swiftly ascended to global prominence as a K-pop powerhouse, with record-breaking achievements since their 2020 debut. Bursting onto the scene with their debut mini-album BORDER : DAY ONE, the group made an immediate impact with unique concepts shaping their artistic identity. In just five years, they’ve placed five albums in the Billboard 200 Top 10, MANIFESTO : DAY 1 (No. 6, 2022), DARK BLOOD (No. 4, 2023), ORANGE BLOOD (No. 4, 2023), ROMANCE : UNTOLD (No. 2, 2024), and DESIRE : UNLEASH (No. 3, 2025). Their 2nd Studio Album, ROMANCE : UNTOLD, marked the group’s career-high, debuting at No. 2 on the Billboard 200 and ranking highest among K-pop acts on the 2024 IFPI Global Album Chart. Building on their chart-topping success, ENHYPEN have expanded their influence globally, achieving an indelible milestone during their 2023 world tour ‘FATE’ with a landmark U.S. stadium debut. The septet performed at Coachella this year, becoming the fastest K-pop boy group to grace the festival. Currently on their ‘WALK THE LINE’ world tour, ENHYPEN are set to bring their scene-stealing shows to the U.S. and make their first-ever Europe stops this summer, further cementing their international presence.

About BELIFT LAB

BELIFT LAB is a label founded jointly by CJ ENM and HYBE, created with the goal of developing idol groups targeting the global market to drive the mainstreaming of K-POP while redefining and innovating the label business. Artists under this label include ENHYPEN (debuted in November of 2020) and ILLIT (debuted in March of 2024).

Keep up with ENHYPEN